ask our doctors

Growth Hormone Deficiency

Get the facts on Growth Hormone Deficiency treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Growth Hormone Deficiency prevention, screening, research, statistics and other Growth Hormone Deficiency related topics. We answer all your qestions about Growth Hormone Deficiency.

Question: what is the average dose of Nutropin AQ a child with growth hormone deficiency takes? Could someone with growth hormone deficiency who takes it tell me what their daily dose is and their weight. thanks.

Answer: IF you are planning on giving this to a child, I would consult the child's physician. Precautions for Pediatric Patients Slipped capital femoral epiphysis may occur more frequently in patients with endocrine disorders (including GH deficiency and Turner syndrome) or in patients undergoing rapid growth. Any pediatric patient with the onset of a limp or complaints of hip or knee pain during somatropin therapy should be carefully evaluated. Children with growth failure secondary to CRI should be examined periodically for evidence of progression of renal osteodystrophy. Slipped capital femoral epiphysis or avascular necrosis of the femoral head may be seen in children with advanced renal osteodystrophy, and it is uncertain whether these problems are affected by somatropin therapy. X‑rays of the hip should be obtained prior to initiating somatropin therapy in CRI patients. Physicians and parents should be alert to the development of a limp or complaints of hip or knee pain in CRI patients treated with Nutropin AQ. Progression of scoliosis can occur in patients who experience rapid growth. Because somatropin increases growth rate, patients with a history of scoliosis who are treated with somatropin should be monitored for progression of scoliosis. However, somatropin has not been shown to increase the occurence of scoliosis. Skeletal abnormalities including scoliosis are commonly seen in untreated Turner syndrome patients. Scoliosis is also commonly seen in untreated patients with Prader‑Willi syndrome. Physicians should be alert to these abnormalities, which may manifest during somatropin therapy. Patients with Turner syndrome should be evaluated carefully for otitis media and other ear disorders since these patients have an increased risk of ear and hearing disorders. In a randomized, controlled trial, there was a statistically significant increase, as compared to untreated controls, in otitis media (43% vs. 26%) and ear disorders (18% vs. 5%) in patients receiving somatropin. In addition, patients with Turner syndrome should be monitored closely for cardiovascular disorders (e.g., stroke, aortic aneurysm/dissection, hypertension) as these patients are also at risk for these conditions. DOSAGE Pediatric Growth Hormone Deficiency (GHD) A weekly dosage of up to 0.3 mg/kg of body weight divided into daily subcutaneous injection is recommended. In pubertal patients, a weekly dosage of up to 0.7 mg/kg divided daily may be used. Also, for more information of dosage, with specific diagnosis, go to this web site, and click on dosage and administration: http://www.nutropin.com/hcp/6_1_3_2_nutr…


Growth Hormone Deficiency News

Daily Mail

Human growth hormone injections became the latest anti-ageing weapon for ...
Daily Mail
 

growth disorder

Malaysia Star
Deficiency of the growth hormone produced in the pituitary gland (located at the base of the brain) is what leads to this condition, say doctors. These hormones tell the pituitary gland how much growth hormone to produce which determines the physical ...
 

Prolor reports positive results in growth hormone pilot study

Globes
This is encouraging news for growth hormone deficient patients who would like to minimize their injection regimen." Havron continued, "We believe that these results demonstrate significant potential, especially in view of the limitations of this pilot ...
 

Prolor announces positive results from post-Phase II hGH-CTP study

Pharmaceutical Business Review
Prolor Biotech has announced positive top-line results from pilot study of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in growth hormone deficient adults. The post-Phase II clinical study data showed that two injections of ...
 

Growth hormone replacement therapy linked to diabetes risk

Diabetes.co.uk
Researchers have claimed that people who are receiving growth hormone (GH) replacement therapy are more at risk of developing diabetes. The study, on over 5000 patients with severe adult-onset GH deficiency, examined data on their HbA1c values, ...
 

Biotech speculators continue to buy into positive attention

Proactive Investors USA & Canada
Dr. Avri Havron, Chief Executive Officer of PROLOR was very encouraged by the findings and hinted that hGH-CTP can potentially provide a safe and effective new therapeutic option for adults with growth hormone deficiency when injected once-weekly, ...
 

HGH's no fountain of youth

Manila Bulletin
Synthetic HGH is a prescription drug that is approved by the US Food and Drug Administration (FDA) for use in the treatment of certain medical conditions such as children's growth disorders and adult growth hormone deficiency.
 

Aeterna Zentaris - An Up Close And Personal Look

NASDAQ
The company has two drug candidates in phase III testing - Perifosine for advanced metastatic colorectal cancer and multiple myeloma, and AEZS-130, a diagnostic test for growth hormone deficiencies. Perifosine is an alkylphospholipid that works by ...
 

GH replacement therapy associated with development of diabetes

Endocrine Today
The incidence of diabetes was increased in patients with growth hormone deficiency who were on growth hormone replacement therapy, according to researchers in Europe. The researchers selected patients from KIMS ? Pfizer International Metabolic ...
 

PROLOR Biotech: A Potentially Attractive Takeover Target

Seeking Alpha
Last August, PROLOR reported positive results from a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in growth hormone deficient adults. The data from the study showed that a single weekly injection of ...